Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial

The Current Practice of Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)

(2018) M. Bushati et al.   EJSO

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

(2018) François Quenet et al.   JOURNAL OF CLINICAL ONCOLOGY

A validated inductively coupled plasma mass spectrometry (ICP-MS) method for the quantification of total platinum content in plasma, plasma ultrafiltrate, urine and peritoneal fluid

(2018) Lieselotte Lemoine et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Pharmacokinetics and Tissue Transport of Intraperitoneal Chemotherapy

(2018) Nick Lagast et al.   Surgical Oncology Clinics of North America

Techniques and Safety Issues for Intraperitoneal Chemotherapy

(2018) Santiago González-Moreno et al.   Surgical Oncology Clinics of North America

Colorectal peritoneal carcinomatosis: What is the future of HIPEC?

(2018) François Quénet   EJSO

Tumour tissue transport after intraperitoneal anticancer drug delivery

(2017) Charlotte Carlier et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma

(2017) Lieselotte Lemoine et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2016) Claramae Shulyn Chia et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of Major Complications on Patients’ Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2016) Trevor D. Hamilton et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors

(2016) Thibaut Charrier et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed

(2016) A.M. Kuijpers et al.   EJSO

Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis

(2015) Yeqian Huang et al.   ANZ JOURNAL OF SURGERY

The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy

(2015) B. Moran et al.   Colorectal Disease

Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy

(2015) A.M. Mehta et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia

(2014) Quentin Chalret du Rieu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy

(2013) Joshua C. Leinwand et al.   ANNALS OF SURGICAL ONCOLOGY

Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view

(2013) Maria Isabel Mas-Fuster et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients

(2013) G. Passot et al.   EJSO

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

(2012) Shigeki Kusamura et al.   JOURNAL OF SURGICAL ONCOLOGY

Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy

(2012) Kurt Van der Speeten et al.   Surgical Oncology Clinics of North America

Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population

(2011) Maryam Derogar et al.   ACTA ONCOLOGICA

Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies

(2011) Shigeki Kusamura et al.   ANNALS OF SURGERY

Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

(2011) Adrienne R. Hill et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

(2010) Jan Franko et al.   CANCER

Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study

(2010) C. Pomel et al.   EJSO

Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?

(2009) Terence C. Chua et al.   ANNALS OF SURGERY

Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas

(2009) Alfonso M. Albanese et al.   SURGICAL AND RADIOLOGIC ANATOMY